These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 11132546)
1. [Pharmacokinetics of cyclophosphamide, adriamycin and adriamycin prodrug (HMR 1928) using an ex vivo isolated perfused human lung model (IHLP)]. Mürdter TE; Linder A; Friedel G; McClellan M; Bohnenstengel F; Sperker B; Kroemer HK; Toomes H; Freitag L; Fritz P Pneumologie; 2000 Nov; 54(11):494-8. PubMed ID: 11132546 [TBL] [Abstract][Full Text] [Related]
2. Enhanced uptake of doxorubicin into bronchial carcinoma: beta-glucuronidase mediates release of doxorubicin from a glucuronide prodrug (HMR 1826) at the tumor site. Mürdter TE; Sperker B; Kivistö KT; McClellan M; Fritz P; Friedel G; Linder A; Bosslet K; Toomes H; Dierkesmann R; Kroemer HK Cancer Res; 1997 Jun; 57(12):2440-5. PubMed ID: 9192823 [TBL] [Abstract][Full Text] [Related]
3. The ex-vivo isolated, perfused human lung model: description and potential applications. Linder A; Friedel G; Fritz P; Kivistö KT; McClellan M; Toomes H Thorac Cardiovasc Surg; 1996 Jun; 44(3):140-6. PubMed ID: 8858797 [TBL] [Abstract][Full Text] [Related]
4. Dose optimization of a doxorubicin prodrug (HMR 1826) in isolated perfused human lungs: low tumor pH promotes prodrug activation by beta-glucuronidase. Mürdter TE; Friedel G; Backman JT; McClellan M; Schick M; Gerken M; Bosslet K; Fritz P; Toomes H; Kroemer HK; Sperker B J Pharmacol Exp Ther; 2002 Apr; 301(1):223-8. PubMed ID: 11907177 [TBL] [Abstract][Full Text] [Related]
5. Variability of cyclophosphamide uptake into human bronchial carcinoma: consequences for local bioactivation. Bohnenstengel F; Friedel G; Ritter CA; McClellan M; Fritz P; Eichelbaum M; Linder A; Toomes H; Dierkesmann R; Kroemer HK Cancer Chemother Pharmacol; 2000; 45(1):63-8. PubMed ID: 10647504 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of doxorubicin in isolated lung of dogs and humans perfused in vivo. Minchin RF; Johnston MR; Aiken MA; Boyd MR J Pharmacol Exp Ther; 1984 Apr; 229(1):193-8. PubMed ID: 6707934 [TBL] [Abstract][Full Text] [Related]
7. Preclinical evaluation of the cardiac toxicity of HMR-1826, a novel prodrug of doxorubicin. Platel D; Bonoron-Adèle S; Dix RK; Robert J Br J Cancer; 1999 Sep; 81(1):24-7. PubMed ID: 10487608 [TBL] [Abstract][Full Text] [Related]
8. Antegrade versus retrograde isolated lung perfusion: doxorubicin uptake and distribution in a sarcoma model. Krueger T; Kuemmerle A; Andrejevic-Blant S; Yan H; Pan Y; Ballini JP; Klepetko W; Decosterd LA; Stupp R; Ris HB Ann Thorac Surg; 2006 Dec; 82(6):2024-30. PubMed ID: 17126104 [TBL] [Abstract][Full Text] [Related]
9. CPI-0004Na, a new extracellularly tumor-activated prodrug of doxorubicin: in vivo toxicity, activity, and tissue distribution confirm tumor cell selectivity. Dubois V; Dasnois L; Lebtahi K; Collot F; Heylen N; Havaux N; Fernandez AM; Lobl TJ; Oliyai C; Nieder M; Shochat D; Yarranton GT; Trouet A Cancer Res; 2002 Apr; 62(8):2327-31. PubMed ID: 11956091 [TBL] [Abstract][Full Text] [Related]
10. Alterations of tumor and normal tissue of human lung cancer resection specimens after isolation perfusion. Nowak K; Hanusch C; Kölbel HC; Schwarzbach M; Post S; Beck G; Gebhard MM; Metzger R; Hohenberger P J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):501-11. PubMed ID: 18204164 [TBL] [Abstract][Full Text] [Related]
11. Distribution of free and liposomal doxorubicin after isolated lung perfusion in a sarcoma model. Yan H; Cheng C; Haouala A; Krueger T; Ballini JP; Peters S; Decosterd LA; Letovanec I; Ris HB; Andrejevic-Blant S Ann Thorac Surg; 2008 Apr; 85(4):1225-32. PubMed ID: 18355500 [TBL] [Abstract][Full Text] [Related]
12. Acute toxicity of irinotecan in the ex-vivo isolated perfused human lung model--high-dose therapy during isolated perfusion without acute toxic lung edema. Biancosino C; Albert M; Linder A Interact Cardiovasc Thorac Surg; 2007 Oct; 6(5):583-7. PubMed ID: 17670737 [TBL] [Abstract][Full Text] [Related]
13. Elucidation of the mechanism enabling tumor selective prodrug monotherapy. Bosslet K; Straub R; Blumrich M; Czech J; Gerken M; Sperker B; Kroemer HK; Gesson JP; Koch M; Monneret C Cancer Res; 1998 Mar; 58(6):1195-201. PubMed ID: 9515805 [TBL] [Abstract][Full Text] [Related]
14. Regional chemotherapy via pulmonary artery with blood flow occlusion in a solitary tumor nodule model. Wang HY; Hochwald S; Ng B; Burt M Anticancer Res; 1996; 16(6B):3749-53. PubMed ID: 9042252 [TBL] [Abstract][Full Text] [Related]
15. Disposition of anticancer drugs after bolus arterial administration in a tissue-isolated tumor perfusion system. Ohkouchi K; Imoto H; Takakura Y; Hashida M; Sezaki H Cancer Res; 1990 Mar; 50(5):1640-4. PubMed ID: 2105843 [TBL] [Abstract][Full Text] [Related]
16. Cathepsin B in infiltrated lymph nodes is of prognostic significance for patients with nonsmall cell lung carcinoma. Werle B; Kraft C; Lah TT; Kos J; Schanzenbächer U; Kayser K; Ebert W; Spiess E Cancer; 2000 Dec; 89(11):2282-91. PubMed ID: 11147599 [TBL] [Abstract][Full Text] [Related]
17. Extracellularly tumor-activated prodrugs for the selective chemotherapy of cancer: application to doxorubicin and preliminary in vitro and in vivo studies. Trouet A; Passioukov A; Van derpoorten K; Fernandez AM; Abarca-Quinones J; Baurain R; Lobl TJ; Oliyai C; Shochat D; Dubois V Cancer Res; 2001 Apr; 61(7):2843-6. PubMed ID: 11306455 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of isolated lung perfusion as neoadjuvant therapy of lung metastases using a novel in vivo pig model: II. High-dose cisplatin is well tolerated by the native lung tissue. Franke UF; Wittwer T; Kaluza M; Albert M; Becker V; Roskos M; Lessel M; Wahlers T Eur J Cardiothorac Surg; 2004 Oct; 26(4):800-6. PubMed ID: 15450576 [TBL] [Abstract][Full Text] [Related]
19. Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor models. Peer D; Dekel Y; Melikhov D; Margalit R Cancer Res; 2004 Oct; 64(20):7562-9. PubMed ID: 15492283 [TBL] [Abstract][Full Text] [Related]